---
schema_version: "secwatch.filing_event.v1"
accession: "0000944809-22-000005"
form_type: "8-K"
ticker: "OPK"
cik: "0000944809"
company_name: "OPKO HEALTH, INC."
filed_at: "2022-01-24T23:59:59+00:00"
generated_at: "2026-06-27T16:24:08.427837+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Dr. Robert Fishel retires from OPKO Health Board effective Jan 21, 2022

## Summary
- Director Robert Fishel retired from the Board on January 21, 2022.
- He served as a director since April 2018 and chaired the Independent Investment Committee.
- He also served on the Compensation and Succession Committees.
- Resignation was not due to any disagreement with the company.

## SEC filing metadata
- accession: 0000944809-22-000005
- form_type: 8-K
- ticker: OPK
- cik: 0000944809
- company_name: OPKO HEALTH, INC.
- filed_at: 2022-01-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/944809/000094480922000005/0000944809-22-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/944809/000094480922000005/opk-20220121.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000944809-22-000005
- JSON: https://secwatch.observer/filing/0000944809-22-000005.json
- Plain text: https://secwatch.observer/filing/0000944809-22-000005.txt

## Key facts
- Executive change
  Dr. Robert Fishel retired as Director at OPKO HEALTH, INC..
  - Action: retired
  - Role: Director
  source text: On January 21, 2022, Dr. Robert Fishel notified OPKO Health, Inc. (the “ Company ”), that he was retiring from service on the Company’s Board of Directors (the “ Board ”), effective January 21, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/944809/000094480922000005/0000944809-22-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.